These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 26635153)

  • 21. The effect of labetalol and propranolol on the development of hypertension in spontaneously hypertensive rats.
    Gumułka WS; Zalewska-Rutczyńska Z
    Acta Physiol Pol; 1984; 35(1):41-6. PubMed ID: 6534080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Systolic time intervals in essential hypertension. II. Variations produced by treatment with labetalol].
    Rossi A; Ziacchi V; Lomanto B
    Arch Mal Coeur Vaiss; 1979 Nov; 72(11):1240-6. PubMed ID: 121529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Absence of labetalol interference on urine metanephrine determination in hypertensive patients].
    Girerd X; Billaud EM; Sorrel-Dejerine A; Ropers J; Safavian A; Safar M; Laurent S
    Arch Mal Coeur Vaiss; 1992 Aug; 85(8):1231-4. PubMed ID: 1482264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A double-blind comparison of verapamil and labetalol in hypertensive patients with coexisting chronic obstructive airways disease.
    Anavekar SN; Barter C; Adam WR; Doyle AE
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S374-7. PubMed ID: 6184571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of labetalol in general medicine in aged patients with hypertension. Compliance, efficacy and safety in long-term treatment].
    Hugonot R; Hugonot L; Herrero G
    Ann Cardiol Angeiol (Paris); 1990 Nov; 39(9):547-53. PubMed ID: 2291621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Results obtained from labetalol therapy in essential hypertension.
    Cagatay G; Soydan I
    Int J Clin Pharmacol Ther Toxicol; 1987 Feb; 25(2):110-2. PubMed ID: 3557731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of hypertension with labetalol.
    Bolli P; Waal-Manning HJ; Simpson FO; Seeman HM
    N Z Med J; 1977 Dec; 86(602):557-63. PubMed ID: 306082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of labetalol in the treatment of severe hypertension during pregnancy.
    Michael CA
    Br J Clin Pharmacol; 1979; 8(Suppl 2):211S-215S. PubMed ID: 526403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experience with labetalol in hypertension.
    Bolli P; Waal-Manning J; Wood AJ; Simpson FO
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):765-71. PubMed ID: 791330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute management of severe hypertension with oral labetalol.
    Ghose RR
    Br J Clin Pharmacol; 1979 Apr; 8 Suppl 2():189S-93S. PubMed ID: 26635165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of labetalol and methyldopa in pregnancy-induced hypertension.
    Lamming GD; Symonds EB
    Br J Clin Pharmacol; 1979; 8(Suppl 2):217S-222S. PubMed ID: 526404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of effect of labetalol on platelet aggregation in hypertensive patients.
    Lin MS; Huang CS
    Int J Clin Pharmacol Ther Toxicol; 1991 Oct; 29(10):391-3. PubMed ID: 1748539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of labetalol in the treatment of severe hypertension during pregnancy.
    Michael CA
    Br J Clin Pharmacol; 1979 Apr; 8 Suppl 2():211S-5S. PubMed ID: 26635169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of labetalol in chronic two-kidney Goldblatt hypertension (2-KGH) in rats.
    Gulati OP; Gulati N
    Arch Int Pharmacodyn Ther; 1980 Feb; 243(2):255-60. PubMed ID: 6990887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Essential arterial hypertension. Effects of labetalol on blood pressure and renin-angiotensin system (author's transl)].
    Martinand A; Lardoux H; Corvol P; Milliez P
    Nouv Presse Med; 1980 Sep; 9(35):2565-8. PubMed ID: 7001349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Labetalol and pindolol in the treatment of hypertension: a comparative study.
    Romo M; Halttunen P; Saarinen P; Sarna S
    Ann Clin Res; 1979 Dec; 11(6):249-52. PubMed ID: 398184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined alpha- and beta-adrenoreceptors blockade with oral labetalol in hypertensive patients with reference to haemodynamic effects at rest and during exercise.
    Koch G
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):729-32. PubMed ID: 10951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of labetalol and methyldopa in pregnancy-induced hypertension.
    Lamming GD; Symonds EB
    Br J Clin Pharmacol; 1979 Apr; 8 Suppl 2():217S-22S. PubMed ID: 26635170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Side-effects with long-term labetalol: an open study of 251 patients in a single centre.
    Tcherdakoff P
    Pharmatherapeutica; 1983; 3(5):342-8. PubMed ID: 6844370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the risk for drug-induced postural hypotension in an experimental model: investigations with carvedilol, prazosin, labetalol, and guanethidine.
    Bartsch W; Sponer G; Strein K; Böhm E; Hooper RG
    J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S49-51. PubMed ID: 2454367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.